Cargando…
Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the clonal expansion of malignant B cells. To predict the clinical course of the disease, the identification of diagnostic biomarkers is urgently needed. Aberrant methylation patterns may predict CLL developmen...
Autores principales: | Loi, Eleonora, Moi, Loredana, Fadda, Antonio, Satta, Giannina, Zucca, Mariagrazia, Sanna, Sonia, Amini Nia, Shadi, Cabras, Giuseppina, Padoan, Marina, Magnani, Corrado, Miligi, Lucia, Piro, Sara, Gentilini, Davide, Ennas, Maria Grazia, Southey, Melissa C., Giles, Graham G., Wong Doo, Nicole, Cocco, Pierluigi, Zavattari, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697638/ https://www.ncbi.nlm.nih.gov/pubmed/31452839 http://dx.doi.org/10.18632/oncotarget.27080 |
Ejemplares similares
-
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study
por: Meloni, Federico, et al.
Publicado: (2021) -
Clustered protocadherins methylation alterations in cancer
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2019) -
Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas
por: Antonelli, Manila, et al.
Publicado: (2018) -
The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study
por: Barberini, Luigi, et al.
Publicado: (2019) -
DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2023)